Issue navigation
Volume 19, Issue 3, March 2025
Editorial
Preventing Post-Colonoscopy Colorectal Cancer in Inflammatory Bowel Disease—“The Big Five”
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae140, https://doi.org/10.1093/ecco-jcc/jjae140
Letter to the Editor
Disease-modifying anti-inflammatory drugs (DMAIDs): shaping the future of inflammatory bowel disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjaf027, https://doi.org/10.1093/ecco-jcc/jjaf027
Letter: Change in Bowel Urgency in Active Ulcerative Colitis Patients Treated with Curcumin-QingDai (CurQD): A Post Hoc Analysis of a Randomized Placebo-Controlled Trial
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae147, https://doi.org/10.1093/ecco-jcc/jjae147
Original Articles
Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae179, https://doi.org/10.1093/ecco-jcc/jjae179
A transcriptomic score to classify the inflammation-dysplasia-cancer sequence lesions in inflammatory bowel disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjaf026, https://doi.org/10.1093/ecco-jcc/jjaf026
The ulcerative colitis risk gene adenylyl cyclase 7 restrains the T-helper 2 phenotype and Class II antigen presentation
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjaf030, https://doi.org/10.1093/ecco-jcc/jjaf030
Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjaf032, https://doi.org/10.1093/ecco-jcc/jjaf032
Independent predictors of 90-day readmission in patients with inflammatory bowel disease: a nationwide retrospective study
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjaf034, https://doi.org/10.1093/ecco-jcc/jjaf034
IL23R-Specific CAR Tregs for the Treatment of Crohn’s Disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae135, https://doi.org/10.1093/ecco-jcc/jjae135
The Impact of Group Cognitive Behavioral Psychotherapy on Disease Severity and Psychosocial Functioning in Patients With Inflammatory Bowel Disease: A Randomized Controlled Study
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae144, https://doi.org/10.1093/ecco-jcc/jjae144
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae145, https://doi.org/10.1093/ecco-jcc/jjae145
Prolonged Time to Diagnosis of Crohn’s Disease in Patients With Perianal Fistulas Negatively Affects Long-Term Outcomes
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae146, https://doi.org/10.1093/ecco-jcc/jjae146
Oxidized Polyunsaturated Fatty Acid Promotes Colitis and Colitis-Associated Tumorigenesis in Mice
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae148, https://doi.org/10.1093/ecco-jcc/jjae148
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae150, https://doi.org/10.1093/ecco-jcc/jjae150
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae151, https://doi.org/10.1093/ecco-jcc/jjae151
Cancer Characteristics, Prognoses, and Mortality of Colorectal Cancer in Patients With Crohn’s Disease—A Danish Nationwide Cohort Study, 2009-2019
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae153, https://doi.org/10.1093/ecco-jcc/jjae153
The Intestinal Mucin Isoform Landscape Reveals Region-Specific Biomarker Panels for Inflammatory Bowel Disease Patient Stratification
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae155, https://doi.org/10.1093/ecco-jcc/jjae155
The Circulating Methylome in Childhood-Onset Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae157, https://doi.org/10.1093/ecco-jcc/jjae157
Mucosal Cytokine Expression Associated With Deep Endoscopic Mucosal Healing in Ulcerative Colitis
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae158, https://doi.org/10.1093/ecco-jcc/jjae158
Crohn’s Disease and Ulcerative Colitis Share 2 Molecular Subtypes With Different Mechanisms and Drug Responses
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae152, https://doi.org/10.1093/ecco-jcc/jjae152
Corrigendum
Corrigendum: Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn’s Disease: A Phase 3 Study
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae149, https://doi.org/10.1093/ecco-jcc/jjae149
Corrections
Correction to: IBD Across the Ages－A Journey Together
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjaf035, https://doi.org/10.1093/ecco-jcc/jjaf035
Correction to: P0722 Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn’s Disease: Results From the One-Year SEQUENCE Open-Label Long-Term Extension
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjaf045, https://doi.org/10.1093/ecco-jcc/jjaf045
